AtriCure, Inc. (ATRC) Announces Preliminary Results for Fourth Quarter and Full Year 2012  
1/7/2013 6:34:00 AM

AtriCure, Inc. (Nasdaq: ATRC), a medical device company and a leader in cardiac surgical ablation systems for the treatment of atrial fibrillation, or AF, and systems for the exclusion of the left atrial appendage, in anticipation of investor meetings in San Francisco during the week of January 7, is announcing preliminary financial results for fourth quarter and full year 2012.